MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.58 (396.79% upside)

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
DateFirmActionRatingPrice TargetActions
8/14/2015MLV & Co.Reiterated RatingBuy$1.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015MLV & Co.Initiated CoverageBuy$1.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014LaidlawInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Brinson PatrickInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2014Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/27/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha